TT/NN
Mutant/JJ
Homozygote/NN
of/IN
Kruppel-like/JJ
Factor/NN
5/CD
Is/VBZ
a/DT
Key/JJ
Factor/NN
for/IN
Increasing/VBG
Basal/JJ
Metabolic/JJ
Rate/NN
and/CC
Resting/VBG
Metabolic/JJ
Rate/NN
in/IN
Korean/JJ
Elementary/JJ
School/NN
Children/NN
./.
====================
We/PRP
investigated/VBD
the/DT
contribution/NN
of/IN
genetic/JJ
variations/NNS
of/IN
KLF5/NN
to/TO
basal/JJ
metabolic/JJ
rate/NN
(/(
BMR/NN
)/)
and/CC
resting/VBG
metabolic/JJ
rate/NN
(/(
RMR/NN
)/)
and/CC
the/DT
inhibition/NN
of/IN
obesity/NN
in/IN
Korean/JJ
children/NN
./.
====================
A/DT
variation/NN
of/IN
KLF5/NN
(/(
rs3782933/NN
)/)
was/VBD
genotyped/VBN
in/IN
62/CD
Korean/NN
children/NN
./.
====================
Using/VBG
multiple/JJ
linear/JJ
regression/NN
analysis/NN
,/,
we/PRP
developed/VBD
a/DT
model/NN
to/TO
predict/VB
BMR/NN
in/IN
children/NN
./.
====================
We/PRP
divided/VBD
them/PRP
into/IN
several/JJ
groups/NNS
;/:
normal/JJ
versus/CC
overweight/JJ
by/IN
body/NN
mass/NN
index/NN
(/(
BMI/NN
)/)
and/CC
low/JJ
BMR/NN
versus/CC
high/JJ
BMR/NN
by/IN
BMR/NN
./.
====================
There/EX
were/VBD
no/DT
differences/NNS
in/IN
the/DT
distributions/NNS
of/IN
alleles/NNS
and/CC
genotypes/NNS
between/IN
each/DT
group/NN
./.
====================
The/DT
genetic/JJ
variation/NN
of/IN
KLF5/NN
gene/NN
showed/VBD
a/DT
significant/JJ
correlation/NN
with/IN
several/JJ
clinical/JJ
factors/NNS
,/,
such/JJ
as/IN
BMR/NN
,/,
muscle/NN
,/,
low-density/JJ
lipoprotein/NN
cholesterol/NN
,/,
and/CC
insulin/NN
./.
====================
Children/NN
with/IN
the/DT
TT/NN
had/VBD
significantly/RB
higher/JJR
BMR/NN
than/IN
those/DT
with/IN
CC/NN
(/(
p/NN
=/JJ
0.030/CD
)/)
./.
====================
The/DT
highest/JJS
muscle/NN
was/VBD
observed/VBN
in/IN
the/DT
children/NN
with/IN
TT/NN
compared/VBN
with/IN
CC/NN
(/(
p/NN
=/JJ
0.032/CD
)/)
./.
====================
The/DT
insulin/NN
and/CC
C-peptide/NN
values/NNS
were/VBD
higher/JJR
in/IN
children/NN
with/IN
TT/NN
than/IN
those/DT
with/IN
CC/NN
(/(
p=/JJ
0.029/CD
vs./CC
p/NN
=/JJ
0.004/CD
,/,
respectively/RB
)/)
./.
====================
In/IN
linear/JJ
regression/NN
analysis/NN
,/,
BMI/NN
and/CC
muscle/NN
mass/NN
were/VBD
correlated/VBN
with/IN
BMR/NN
,/,
whereas/IN
insulin/NN
and/CC
C-peptide/NN
were/VBD
not/RB
associated/VBN
with/IN
BMR/NN
./.
====================
In/IN
the/DT
high-BMR/JJ
group/NN
,/,
we/PRP
observed/VBD
that/IN
higher/JJR
muscle/NN
,/,
fat/JJ
mass/NN
,/,
and/CC
C-peptide/NN
affect/VB
the/DT
increase/NN
of/IN
BMR/NN
in/IN
children/NN
with/IN
TT/NN
(/(
p/NN
</JJR
0.001/CD
,/,
p/NN
</JJR
0.001/CD
,/,
and/CC
p/NN
=/JJ
0.018/CD
,/,
respectively/RB
)/)
,/,
while/IN
Rohrer/NNP
's/POS
index/NN
could/MD
explain/VB
the/DT
usual/JJ
decrease/NN
in/IN
BMR/NN
(/(
adjust/RB
r2/NN
=/JJ
1.000/CD
,/,
p/NN
</JJR
0.001/CD
,/,
respectively/RB
)/)
./.
====================
We/PRP
identified/VBD
a/DT
novel/JJ
association/NN
between/IN
TT/NN
of/IN
KLF5/NN
rs3782933/NN
and/CC
BMR/NN
in/IN
Korean/JJ
children/NN
./.
====================
We/PRP
could/MD
make/VB
better/RBR
use/NN
of/IN
the/DT
variation/NN
within/IN
KLF5/NN
in/IN
a/DT
future/JJ
clinical/JJ
intervention/NN
study/NN
of/IN
obesity/NN
./.
====================
Kruppel-like/JJ
factors/NNS
(/(
KLFs/NNS
)/)
are/VBP
zinc-finger/JJ
transcription/NN
factors/NNS
considered/VBN
to/TO
be/VB
crucial/JJ
regulators/NNS
of/IN
cell/NN
differentiation/NN
,/,
development/NN
,/,
and/CC
cell/NN
cycle/NN
progression/NN
[/(
1/CD
]/)
./.
====================
Each/DT
KLF/NN
has/VBZ
its/PRP$
own/JJ
function/NN
and/CC
acts/VBZ
as/IN
a/DT
transcriptional/JJ
activator/NN
or/CC
repressor/NN
,/,
depending/VBG
on/IN
the/DT
promoters/NNS
[/(
2/CD
]/)
./.
====================
Several/JJ
features/NNS
distinguish/VBP
KLFs/NNS
from/IN
the/DT
highly/RB
conserved/VBN
classical/JJ
zinc-finger/NN
transcription/NN
factors/NNS
[/(
2/CD
,/,
3/CD
]/)
./.
====================
Zinc-fingers/NNS
are/VBP
located/JJ
at/IN
the/DT
carboxyl/JJ
terminus/NN
of/IN
the/DT
protein/NN
and/CC
permit/VBP
KLFs/NNS
to/TO
bind/VB
to/TO
related/JJ
GC-/NN
and/CC
CACCC-boxes/NNS
of/IN
DNA/NN
[/(
4/CD
]/)
./.
====================
In/IN
contrast/NN
to/TO
the/DT
zinc-finger/NN
regions/NNS
,/,
the/DT
non-DNA-binding/JJ
regions/NNS
are/VBP
highly/RB
controversial/JJ
,/,
regulate/VBP
activation/NN
and/CC
repression/NN
,/,
and/CC
often/RB
mediate/VBP
interaction/NN
of/IN
protein-protein/JJ
[/(
3/CD
]/)
./.
====================
Recently/RB
,/,
a/DT
potential/JJ
role/NN
for/IN
KLFs/NNS
in/IN
adipogenesis/NN
has/VBZ
been/VBN
suggested/VBN
[/(
5/CD
]/)
./.
====================
For/IN
example/NN
,/,
KLF5/NN
and/CC
KLF2/NN
are/VBP
expressed/VBN
in/IN
3T3-L1/NN
preadipocytes/VBZ
and/CC
bind/VBP
directly/RB
to/TO
the/DT
peroxisome/NN
proliferator-activated/JJ
receptor/NN
γ2/NN
(/(
PPARγ2/NN
)/)
promoter/NN
or/CC
inhibit/VBP
its/PRP$
activity/NN
[/(
6/CD
]/)
./.
====================
KLF5/NN
(/(
also/RB
known/VBN
as/IN
BTEB2/NN
or/CC
IKLF/NN
)/)
was/VBD
first/JJ
identified/VBD
as/IN
a/DT
transcription/NN
factor/NN
for/IN
SMemb/non-muscle/NN
myosin/JJ
heavy/JJ
chain-B/NN
(/(
NMHC-B/NN
)/)
,/,
a/DT
marker/NN
of/IN
smooth/JJ
muscle/NN
cells/NNS
in/IN
vascular/JJ
disease/NN
[/(
7/CD
]/)
./.
====================
KLF5/NN
upregulates/VBZ
in/IN
activated/VBN
smooth/JJ
muscle/NN
cells/NNS
or/CC
fibroblasts/NNS
of/IN
vascular/JJ
lesions/NNS
and/CC
downregulates/VBZ
in/IN
adult/JJ
vessels/NNS
[/(
7/CD
,/,
8/CD
]/)
KLF5/NN
binds/VBZ
directly/RB
to/TO
the/DT
PPARγ/NN
promoter/NN
,/,
and/CC
PPARγ/NN
activity/NN
can/MD
be/VB
enhanced/VBN
by/IN
either/CC
C/EBPβ/NN
or/CC
C/EBPδ/JJ
[/(
4/CD
]/)
./.
====================
Therefore/RB
,/,
several/JJ
studies/NNS
suggested/VBD
KLF5/NN
is/VBZ
downstream/JJ
of/IN
C/EBPβ/JJ
or/CC
C/EBPδ/JJ
and/CC
upstream/RB
of/IN
PPARγ/NN
during/IN
adipocyte/NN
differentiation/NN
[/(
4/CD
,/,
5/CD
]/)
./.
====================
Just/NN
like/IN
KLF2/NN
,/,
KLF5/NN
might/MD
contribute/VB
to/TO
adipogenesis/NN
transcriptional/JJ
regulation/NN
via/IN
PPARγ/NN
./.
====================
KLF15/CD
induces/VBZ
differentiation/NN
of/IN
3T3-L1/NN
in/IN
the/DT
late/JJ
stage/NN
and/CC
expression/NN
of/IN
the/DT
glucose/NN
transporter/NN
GLUT4/NN
[/(
9/CD
]/)
./.
====================
KLF7/NN
is/VBZ
expressed/VBN
in/IN
adipocytes/NNS
,/,
as/IN
well/RB
as/IN
several/JJ
human/JJ
tissues/NNS
,/,
such/JJ
as/IN
pancreas/NN
,/,
skeletal/JJ
muscle/NN
,/,
and/CC
liver/NN
[/(
10/CD
]/)
./.
====================
However/RB
,/,
the/DT
functions/NNS
of/IN
these/DT
KLFs/NNS
in/IN
adipocyte/NN
differentiation/NN
in/IN
vivo/FW
remain/VBP
unclear/JJ
./.
====================
The/DT
prevalence/NN
of/IN
overweight/JJ
and/CC
obesity/NN
is/VBZ
increasing/VBG
worldwide/NN
./.
====================
The/DT
imbalance/NN
between/IN
energy/NN
expenditures/VBZ
and/CC
energy/NN
intakes/VBZ
causes/VBZ
excessive/JJ
fat/NN
accumulation/NN
,/,
leading/VBG
to/TO
an/DT
increase/NN
of/IN
the/DT
number/NN
and/or/CC
size/NN
of/IN
fat/JJ
cells/NNS
[/(
4/CD
]/)
./.
====================
Basal/JJ
metabolic/JJ
rate/NN
(/(
BMR/NN
)/)
is/VBZ
the/DT
minimum/JJ
energy/NN
required/VBN
to/TO
retain/VB
the/DT
physiological/JJ
functions/NNS
of/IN
the/DT
body/NN
while/IN
awake/NN
./.
====================
BMR/NN
accounts/NNS
for/IN
approximately/RB
45/CD
%/NN
to/TO
70/CD
%/NN
of/IN
total/JJ
energy/NN
expenditure/NN
in/IN
most/JJS
healthy/JJ
adults/NNS
and/CC
is/VBZ
affected/VBN
by/IN
age/NN
,/,
gender/RB
,/,
body/NN
surface/NN
area/NN
,/,
body/NN
composition/NN
,/,
genetic/JJ
composition/NN
,/,
pregnancy/NN
,/,
and/CC
hormonal/JJ
status/NN
directly/RB
[/(
11/CD
,/,
12/CD
]/)
./.
====================
Thus/RB
,/,
estimating/VBG
BMR/NN
is/VBZ
important/JJ
for/IN
establishing/VBG
strategies/NNS
of/IN
obesity/NN
prevention/NN
programs/NNS
[/(
11/CD
]/)
./.
====================
For/IN
several/JJ
years/NNS
,/,
numerous/JJ
predictive/JJ
equations/NNS
for/IN
BMR/NN
have/VBP
been/VBN
developed/VBN
in/IN
different/JJ
populations/NNS
./.
====================
Although/IN
many/JJ
studies/NNS
have/VBP
shown/VBN
the/DT
influence/NN
of/IN
ethnicity/NN
on/IN
BMR/NN
,/,
their/PRP$
results/NNS
have/VBP
been/VBN
inconsistent/JJ
[/(
11/CD
,/,
12/CD
]/)
./.
====================
On/IN
the/DT
other/JJ
hand/NN
,/,
resting/VBG
metabolic/JJ
rate/NN
(/(
RMR/NN
)/)
is/VBZ
also/RB
the/DT
energy/NN
requirement/NN
to/TO
support/VB
vital/JJ
functions/NNS
while/IN
resting/VBG
in/IN
the/DT
supine/NN
position/NN
./.
====================
Just/NN
like/IN
the/DT
BMR/NN
,/,
RMR/NN
is/VBZ
quantitatively/RB
the/DT
largest/JJS
component/NN
of/IN
daily/RB
energy/NN
expenditure/NN
(/(
60-75/CD
%/NN
)/)
./.
====================
In/IN
order/NN
to/TO
evaluate/VB
RMR/NN
,/,
direct/JJ
and/CC
indirect/JJ
calorimeters/NNS
,/,
such/JJ
as/IN
whole-room/JJ
calorimeters/NNS
,/,
open-circuit/VBP
Douglas/NNS
bag/NN
method/NN
,/,
metabolic/JJ
carts/NNS
,/,
and/CC
ventilated/JJ
hood/NN
systems/NNS
,/,
are/VBP
required/VBN
,/,
and/CC
these/DT
methods/NNS
are/VBP
not/RB
helpful/JJ
nor/CC
cost-effective/JJ
for/IN
large-scale/JJ
epidemiological/JJ
studies/NNS
./.
====================
Therefore/RB
,/,
regression/NN
equations/NNS
have/VBP
been/VBN
used/VBN
to/TO
estimate/VB
resting/VBG
energy/NN
requirements/NNS
in/IN
large/JJ
populations/NNS
[/(
13/CD
]/)
./.
====================
So/RB
far/RB
,/,
several/JJ
studies/NNS
have/VBP
suggested/VBN
that/IN
uncoupling/VBG
protein/NN
2/CD
(/(
UCP2/NN
)/)
is/VBZ
involved/VBN
in/IN
the/DT
regulation/NN
of/IN
energy/NN
expenditure/NN
metabolism/NN
,/,
body/NN
weight/NN
,/,
and/CC
obesity/NN
[/(
14/CD
]/)
./.
====================
In/IN
other/JJ
studies/NNS
,/,
the/DT
polymorphism/NN
of/IN
the/DT
uncoupling/JJ
protein/NN
1/CD
(/(
UCP1/NN
)/)
gene/NN
did/VBD
not/RB
have/VB
an/DT
independent/JJ
effect/NN
on/IN
BMR/NN
;/:
however/RB
,/,
its/PRP$
synergistic/JJ
effect/NN
with/IN
the/DT
beta3-AR/JJ
gene/NN
polymorphism/NN
induced/VBD
a/DT
lower/JJR
BMR/NN
than/IN
the/DT
polymorphism/NN
of/IN
beta3-AR/JJ
gene/NN
alone/RB
[/(
15/CD
]/)
./.
====================
Recently/RB
,/,
to/TO
investigate/VB
the/DT
clinical/JJ
relevance/NN
of/IN
KLF5/NN
in/IN
complex/NN
diseases/NNS
,/,
such/JJ
as/IN
cardiovascular/JJ
disease/NN
,/,
several/JJ
single-nucleotide/JJ
polymorphisms/NNS
(/(
SNPs/NNS
)/)
within/IN
KLF5/NN
have/VBP
been/VBN
analyzed/VBN
;/:
however/RB
,/,
an/DT
association/NN
of/IN
KLF5/NN
SNPs/NNS
with/IN
BMR/NN
of/IN
children/NN
has/VBZ
not/RB
been/VBN
identified/VBN
yet/RB
./.
====================
The/DT
purpose/NN
of/IN
this/DT
study/NN
is/VBZ
1/CD
)/)
to/TO
identify/VB
the/DT
contribution/NN
of/IN
novel/JJ
genetic/JJ
variations/NNS
of/IN
KLF5/NN
to/TO
increased/VBN
BMR/NN
and/CC
the/DT
suppression/NN
of/IN
obesity/NN
in/IN
Korean/JJ
children/NN
and/CC
2/CD
)/)
to/TO
make/VB
better/RBR
use/NN
of/IN
the/DT
alterations/NNS
of/IN
KLF5/NN
in/IN
future/JJ
clinical/JJ
intervention/NN
studies/NNS
./.
====================
Study/NN
population/NN
====================
A/DT
total/JJ
of/IN
62/CD
eligible/JJ
subjects/NNS
were/VBD
recruited/VBN
from/IN
3rd/JJ
grade/NN
to/TO
6th/DT
grade/NN
students/NNS
of/IN
elementary/JJ
schools/NNS
in/IN
2005/CD
./.
====================
Ethical/JJ
permission/NN
for/IN
the/DT
study/NN
was/VBD
obtained/VBN
from/IN
the/DT
Institutional/JJ
Review/NN
Boards/NNS
,/,
and/CC
all/DT
subjects/NNS
provided/VBD
written/CD
informed/VBN
consent/NN
./.
====================
Demographics/NNS
of/IN
age/NN
,/,
gender/RB
,/,
weight/NN
,/,
height/RB
,/,
body/NN
mass/NN
index/NN
(/(
BMI/NN
)/)
,/,
fat/JJ
mass/NN
,/,
muscle/NN
,/,
waist-hip/NN
ratio/NN
(/(
WHR/NN
)/)
,/,
and/CC
BMR/NN
,/,
as/IN
well/RB
as/IN
skinfold/RB
thickness/DT
,/,
lipid/NN
profile/NN
,/,
and/CC
hematological/JJ
data/NNS
,/,
were/VBD
also/RB
recorded/VBD
./.
====================
All/DT
variables/NNS
were/VBD
measured/VBN
for/IN
developing/VBG
the/DT
predictive/JJ
equation/NN
model/NN
of/IN
BMR/NN
./.
====================
Anthropometric/JJ
measurements/NNS
====================
All/DT
measurements/NNS
were/VBD
made/VBN
using/VBG
standard/JJ
techniques/NNS
./.
====================
The/DT
standing/NN
height/NN
was/VBD
measured/VBN
with/IN
a/DT
stadiometer/NN
(/(
Jenix/NN
)/)
attached/VBD
to/TO
a/DT
wall/NN
./.
====================
Weight/PRP
,/,
height/RB
,/,
fat/NN
mass/NN
,/,
muscle/NN
mass/NN
,/,
and/CC
WHR/NN
were/VBD
measured/VBN
by/IN
bioelectrical/JJ
impedance/VBP
analysis/NN
(/(
Inbody/NN
720/CD
;/:
Biospace/NNP
,/,
Seoul/JJ
,/,
Korea/NN
)/)
./.
====================
BMI/NN
was/VBD
calculated/VBN
by/IN
dividing/VBG
weight/NN
(/(
kg/NN
)/)
by/IN
the/DT
square/NN
of/IN
height/NN
(/(
m/NN
)/)
./.
====================
Subjects/NNS
were/VBD
divided/VBN
into/IN
two/CD
groups/NNS
by/IN
the/DT
85/CD
percentile/IN
of/IN
BMI/NN
values/NNS
./.
====================
Children/NN
with/IN
normal/JJ
weight/NN
were/VBD
the/DT
lower/JJR
BMI/NN
group/NN
(/(
BMI/NN
</JJR
85th/DT
)/)
,/,
and/CC
the/DT
higher/JJR
BMI/NN
group/NN
was/VBD
overweight/VBN
(/(
BMI/NN
≥/CD
85th/DT
)/)
./.
====================
Also/RB
,/,
Rohrer/NNP
index/NN
(/(
RI/NN
)/)
was/VBD
measured/VBN
by/IN
height/NN
and/CC
weight/NN
for/IN
obesity/NN
judgment/JJ
./.
====================
Skinfold/JJ
thickness/DT
of/IN
the/DT
triceps/NNS
and/CC
subscapular/JJ
and/CC
suprailiac/JJ
regions/NNS
were/VBD
measured/VBN
by/IN
caliper/JJ
(/(
Cambridge/NN
Scientific/JJ
Industries/NNS
,/,
Cambridge/NN
,/,
MD/NN
,/,
USA/NN
)/)
./.
====================
RMR/NN
and/CC
BMR/NN
measurements/NNS
====================
RMR/NN
was/VBD
measured/VBN
using/VBG
a/DT
MedGem/JJ
metabolic/JJ
analyzer/NN
(/(
Microlife/NN
USA/NN
,/,
Dunedin/NN
,/,
FL/NN
,/,
USA/NN
)/)
[/(
16/CD
]/)
./.
====================
This/DT
device/RB
is/VBZ
a/DT
handheld/NN
indirect/JJ
calorimeter/NN
used/VBN
for/IN
its/PRP$
accuracy/NN
and/CC
portability/NN
in/IN
clinical/JJ
settings/NNS
and/CC
is/VBZ
becoming/VBG
popular/JJ
in/IN
research/NN
studies/NNS
as/IN
a/DT
screening/NN
tool/NN
and/CC
a/DT
criterion/JJ
measure/VB
of/IN
RMR/NN
./.
====================
This/DT
device/RB
calculates/NNS
RMR/NN
using/VBG
florescent/JJ
quenching/VBG
of/IN
ruthenium/NN
in/IN
the/DT
presence/NN
of/IN
oxygen/NN
and/CC
the/DT
modified/VBN
Weir/PRP$
equation/NN
,/,
with/IN
an/DT
assumed/VBN
respiration/NN
quotient/JJ
of/IN
0.85/CD
to/TO
estimate/VB
carbon/JJ
dioxide/NN
production/NN
[/(
17/CD
]/)
./.
====================
Prior/JJ
to/TO
each/DT
measurement/NN
,/,
the/DT
MedGem/NN
was/VBD
autocalibrated/VBN
on/IN
zero/CD
airflow/NN
according/VBG
to/TO
the/DT
manufacturer/NN
's/POS
instructions/NNS
./.
====================
Participants/NNS
rested/JJ
in/IN
the/DT
supine/NN
position/NN
on/IN
a/DT
dormitory/JJ
bed/VBN
with/IN
a/DT
pillow/JJ
for/IN
15/CD
min/NN
in/IN
a/DT
climate-controlled/JJ
laboratory/NN
,/,
where/WRB
lights/NNS
were/VBD
dimmed/VBN
and/CC
the/DT
setting/VBG
was/VBD
quiet/RB
./.
====================
Following/VBG
this/DT
rest/NN
period/NN
,/,
participants/NNS
were/VBD
asked/VBN
to/TO
breathe/DT
through/IN
a/DT
mouthpiece/NN
in/IN
a/DT
relaxed/JJ
fashion/NN
for/IN
approximately/RB
7-10/CD
min/NN
,/,
depending/VBG
on/IN
the/DT
stability/NN
of/IN
the/DT
VO2/NN
measures/NNS
./.
====================
The/DT
participants/NNS
were/VBD
allowed/VBN
to/TO
hold/JJ
the/DT
mouthpiece/NN
in/IN
their/PRP$
mouth/NN
during/IN
the/DT
measurement/NN
if/IN
they/PRP
felt/VBP
it/PRP
necessary/JJ
./.
====================
Once/RB
the/DT
participant/JJ
had/VBD
reached/VBN
steady-state/JJ
oxygen/NN
consumption/NN
,/,
as/IN
measured/VBN
by/IN
the/DT
MedGem/NN
,/,
data/NNS
collection/NN
was/VBD
completed/VBN
./.
====================
If/IN
the/DT
children/NN
were/VBD
unable/JJ
to/TO
reach/VB
steady-state/JJ
oxygen/NN
consumption/NN
in/IN
the/DT
allotted/JJ
time/NN
of/IN
approximately/RB
10/CD
min/NN
,/,
the/DT
test/NN
was/VBD
terminated/VBN
at/IN
10/CD
min/NN
by/IN
the/DT
device/JJ
,/,
and/CC
RMR/NN
was/VBD
calculated/VBN
as/IN
a/DT
mathematical/JJ
average/NN
from/IN
the/DT
final/JJ
8/CD
min/NN
of/IN
data/NNS
collection/NN
./.
====================
The/DT
MedGem/NN
then/RB
calculated/VBN
steady-state/JJ
RMR/NN
for/IN
a/DT
24-h/JJ
period/NN
(/(
kcal/day/JJ
)/)
[/(
13/CD
]/)
./.
====================
BMR/NN
was/VBD
measured/VBN
using/VBG
indirect/JJ
calorimetry/NN
./.
====================
All/DT
measurements/NNS
were/VBD
repeated/VBN
three/CD
times/NNS
./.
====================
Blood/NN
biochemistry/NN
====================
Blood/NN
samples/NNS
were/VBD
collected/VBN
after/IN
12-h/JJ
fasting/JJ
and/CC
were/VBD
immediately/RB
placed/VBN
in/IN
4℃/CD
./.
====================
For/IN
genotyping/VBG
,/,
whole/JJ
blood/NN
was/VBD
collected/VBN
in/IN
ethylenediaminetetraacetic/JJ
acid-treated/JJ
tubes/NNS
./.
====================
For/IN
other/JJ
blood/NN
profiles/NNS
,/,
blood/NN
samples/NNS
were/VBD
collected/VBN
in/IN
serum/NN
separator/NN
tubes/NNS
and/CC
centrifuged/JJ
at/IN
3,000/CD
rpm/NN
for/IN
20/CD
min/NN
at/IN
4℃/CD
./.
====================
Serum/NN
samples/NNS
were/VBD
frozen/VBN
at/IN
-80℃/CD
until/IN
used/VBN
./.
====================
Levels/NNS
of/IN
total/JJ
cholesterol/NN
(/(
TC/NN
)/)
,/,
triglyceride/NN
(/(
TG/NN
)/)
,/,
high-density/JJ
lipoprotein/NN
cholesterol/NN
(/(
HDL-C/NN
)/)
,/,
apolipoprotein/NN
B/NN
,/,
apolipoprotein/NN
A1/NN
,/,
and/CC
C-reactive/JJ
protein/NN
were/VBD
measured/VBN
by/IN
an/DT
auto/JJ
analyzer/CC
(/(
Boeringer/NNP
Mannheim/JJ
,/,
Mannheim/JJ
,/,
Germany/NNP
)/)
./.
====================
Low-density/JJ
lipoprotein/NN
cholesterol/NN
(/(
LDL-C/NN
)/)
was/VBD
calculated/VBN
as/IN
described/VBN
by/IN
the/DT
Friedewald/JJ
and/CC
Laucer/NN
equation/NN
[/(
18/CD
,/,
19/CD
]/)
:/:
LDL-C/NN
=/JJ
TC/NN
-/:
HDL-C-/NN
(/(
TG/5/NN
)/)
./.
====================
Levels/NNS
of/IN
fasting/JJ
glucose/NN
were/VBD
measured/VBN
by/IN
using/VBG
an/DT
autoanalyzer/NN
(/(
Ekachem/NNP
DTSC/NN
module/NN
;/:
Johnson/NNP
&/CC
Johnson/NN
,/,
New/NN
Brunswick/NN
,/,
NJ/NN
,/,
USA/NN
)/)
./.
====================
Fasting/VBG
insulin/NN
was/VBD
measured/VBN
by/IN
glucotrend/NN
(/(
Roche/NNP
,/,
Mannheim/NNP
,/,
Germany/NNP
)/)
,/,
and/CC
homeostasis/NN
model/NN
assessment/NN
of/IN
insulin/NN
resistance/NN
(/(
HOMA-IR/NN
)/)
was/VBD
calculated/VBN
as/IN
described/VBN
by/IN
Matthews/NNS
equation/JJ
[/(
20/CD
]/)
:/:
HOMA-IR/NN
=/JJ
fasting/VBG
glucose/NN
(/(
mmol/L/NN
)/)
/22.5/CD
×/NNP
insulin/NN
(/(
µL/mL/NNS
)/)
,/,
fasting/VBG
glucose/NN
(/(
mmol/L/NN
)/)
=/JJ
fasting/VBG
glucose/NN
(/(
mg/mL/NNS
)/)
×/RB
0.0555/CD
./.
====================
Analysis/NN
of/IN
the/DT
KLF5/NN
SNP/NN
====================
The/DT
polymorphisms/NNS
for/IN
the/DT
KLF5/NN
(/(
rs3782933/NN
)/)
gene/NN
were/VBD
analyzed/VBN
(/(
http/NN
:/:
//www.ncbi.nlm.gov//JJ
)/)
./.
====================
For/IN
each/DT
sample/NN
,/,
the/DT
genomic/JJ
DNA/NN
was/VBD
isolated/VBN
from/IN
whole/JJ
blood/NN
using/VBG
the/DT
QIAamp/NN
DNA/NN
blood/NN
mini/NNS
kit/NN
(/(
Qiagen/NN
,/,
Valencia/NN
,/,
CA/NNP
,/,
USA/NNP
)/)
according/VBG
to/TO
the/DT
supplier/NN
's/POS
instructions/NNS
./.
====================
PCR/NN
was/VBD
performed/VBN
using/VBG
the/DT
Takara/NN
DNA/NN
Polymerase/NN
Kit/NN
(/(
Takara/NN
Bio/NN
Inc/NNP
,/,
Shiga/NN
,/,
Japan/NNP
)/)
./.
====================
All/DT
the/DT
primers/NNS
for/IN
PCR/NN
amplification/NN
and/CC
DNA/NN
sequencing/NN
were/VBD
designed/VBN
using/VBG
the/DT
Primer3/NN
software/JJ
(/(
http/NN
:/:
//Frodo.wi.mit.edu/cgi-bin/primer3/primer3/NN
)/)
;/:
the/DT
sequences/NNS
are/VBP
available/JJ
upon/IN
request/VBP
./.
====================
PCR/NN
reactions/NNS
were/VBD
carried/VBN
out/RP
in/IN
a/DT
final/JJ
volume/NN
of/IN
25/CD
µL/NN
containing/VBG
10×/CD
buffer/NN
,/,
1.5/CD
mmol/L/NN
MgCl2/NN
,/,
20/CD
µmol/L/NN
dNTP/NN
,/,
0.5/CD
µmol/L/NN
of/IN
each/DT
primer/NN
,/,
10/CD
ng/NN
of/IN
genomic/JJ
DNA/NN
as/IN
template/JJ
,/,
and/CC
0.5/CD
U/NNP
polymerase/NN
./.
====================
Each/DT
PCR/NN
product/NN
was/VBD
purified/VBN
and/CC
subjected/VBD
to/TO
DNA/NN
sequencing/NN
by/IN
using/VBG
the/DT
QIAquick/NN
PCR/NN
purification/NN
Kit/NN
(/(
Qiagen/NN
)/)
and/CC
the/DT
ABI/NN
Prism/NN
genetic/JJ
analyzer/NN
(/(
Applied/VBN
Biosystems/NNS
,/,
Foster/NN
City/NN
,/,
CA/NNP
,/,
USA/NNP
)/)
after/IN
confirming/VBG
the/DT
purity/NN
and/CC
mobility/NN
of/IN
each/DT
PCR/NN
product/NN
by/IN
agarose/DT
gel/NN
electrophoresis/NN
./.
====================
Each/DT
sample/NN
was/VBD
sequenced/VBN
for/IN
both/DT
strands/NNS
to/TO
confirm/VB
results/NNS
./.
====================
Statistical/JJ
analysis/NN
====================
The/DT
results/NNS
are/VBP
presented/VBN
as/IN
mean/JJ
±/CD
standard/JJ
error/NN
range/NN
./.
====================
p-values/NNS
for/IN
each/DT
genotype/NN
and/CC
allele/NN
were/VBD
evaluated/VBN
by/IN
χ2/NN
analysis/NN
and/CC
Fisher/NN
's/POS
exact/JJ
test/NN
./.
====================
A/DT
p-value/JJ
of/IN
</JJR
0.05/CD
was/VBD
considered/VBN
to/TO
indicate/VB
a/DT
statistically/RB
significant/JJ
difference/NN
between/IN
obese/DT
subjects/NNS
and/CC
normal-weight/JJ
subjects/NNS
of/IN
the/DT
study/NN
./.
====================
Associations/NNS
of/IN
clinical/JJ
variables/NNS
,/,
such/JJ
as/IN
age/NN
,/,
BMI/NN
,/,
height/RB
,/,
weight/NN
,/,
and/CC
BMR/NN
,/,
were/VBD
analyzed/VBN
by/IN
Pearson/NN
correlation/NN
test/NN
./.
====================
Multiple/JJ
linear/JJ
regression/NN
analysis/NN
was/VBD
performed/VBN
to/TO
develop/VB
a/DT
BMR/NN
equation/NN
./.
====================
All/DT
analyses/NNS
were/VBD
performed/VBN
using/VBG
SPSS/NN
version/NN
18.0/CD
(/(
SPSS/NN
Inc./NNP
,/,
Chicago/JJ
,/,
IL/NN
,/,
USA/NN
)/)
./.
====================
Distribution/NN
of/IN
genotypes/NNS
and/CC
alleles/NNS
of/IN
KLF5/NN
gene/NN
====================
The/DT
recruited/VBN
62/CD
children/NN
were/VBD
aged/JJ
11.51/CD
±/CD
0.97/CD
y/RB
,/,
and/CC
girls/VBZ
made/VBD
up/IN
more/RBR
than/IN
half/DT
of/IN
the/DT
children/NN
recruited/VBN
(/(
n/NN
=/JJ
33/CD
,/,
53.2/CD
%/NN
)/)
./.
====================
Mean/JJ
BMI/NN
estimated/VBN
from/IN
height/NN
and/CC
weight/NN
was/VBD
20.26/CD
±/CD
3.41/CD
kg/m2/NN
./.
====================
The/DT
average/JJ
BMR/NN
was/VBD
1,018.42/CD
±/CD
113.86/CD
kcal/day/JJ
,/,
and/CC
muscle/NN
averaged/JJ
28.26/CD
±/CD
4.99/CD
kg/NN
(/(
data/NNS
not/RB
shown/VBN
)/)
./.
====================
Children/NN
with/IN
the/DT
C/NN
allele/NN
were/VBD
nearly/RB
twice/RB
those/DT
with/IN
the/DT
T/NN
allele/NN
in/IN
each/DT
group/NN
./.
====================
In/IN
the/DT
overweight/JJ
group/NN
,/,
allele/NN
frequencies/NNS
were/VBD
67.6/CD
%/NN
for/IN
C/NN
allele/NN
and/CC
32.4/CD
%/NN
for/IN
T/NN
allele/NN
./.
====================
However/RB
,/,
we/PRP
found/VBD
no/DT
statistical/JJ
significance/NN
between/IN
the/DT
frequencies/NNS
of/IN
alleles/NNS
and/CC
genotypes/NNS
in/IN
two/CD
groups/NNS
(/(
Table/JJ
1/CD
)/)
./.
====================
On/IN
the/DT
other/JJ
hand/NN
,/,
four/CD
children/NN
had/VBD
TT/NN
genotype/NN
in/IN
the/DT
high-BMR/JJ
group/NN
and/CC
only/RB
one/CD
child/JJ
had/VBD
TT/NN
genotype/NN
in/IN
the/DT
low-BMR/JJ
group/NN
./.
====================
Thus/RB
,/,
four/CD
in/IN
five/CD
children/NN
with/IN
the/DT
TT/NN
genotype/NN
belong/IN
to/TO
the/DT
high-BMR/JJ
group/NN
./.
====================
However/RB
,/,
there/EX
were/VBD
no/DT
differences/NNS
of/IN
alleles/NNS
and/CC
genotypes/NNS
in/IN
the/DT
low-/JJ
and/CC
high-BMR/JJ
groups/NNS
(/(
Table/JJ
1/CD
)/)
./.
====================
Clinical/JJ
characteristics/NNS
of/IN
62/CD
children/NN
according/VBG
to/TO
genotype/NN
of/IN
rs3782933/CD
====================
The/DT
p-values/NNS
for/IN
Hardy-Weinberg/JJ
equilibrium/NN
and/CC
minor/JJ
allele/NN
frequency/NN
of/IN
KLF/NN
rs3782933/NN
were/VBD
0.8286/CD
and/CC
0.3333/CD
,/,
respectively/RB
./.
====================
The/DT
SNP/NN
of/IN
KLF5/NN
showed/VBD
significant/JJ
differences/NNS
with/IN
several/JJ
clinical/JJ
factors/NNS
,/,
such/JJ
as/IN
BMR/NN
,/,
muscle/NN
,/,
LDL-C/NN
,/,
insulin/NN
,/,
and/CC
C-peptide/NN
(/(
Table/JJ
2/CD
)/)
./.
====================
Children/NN
with/IN
the/DT
TT/NN
genotype/NN
had/VBD
significantly/RB
higher/JJR
BMR/NN
than/IN
those/DT
with/IN
the/DT
wild-type/JJ
(/(
CC/NN
genotype/NN
)/)
(/(
p/NN
=/JJ
0.030/CD
)/)
./.
====================
The/DT
highly/RB
correlated/VBD
factors/NNS
with/IN
BMR/NN
,/,
such/JJ
as/IN
height/RB
and/CC
muscle/NN
composition/NN
,/,
were/VBD
also/RB
higher/JJR
in/IN
children/NN
with/IN
the/DT
TT/NN
genotype/NN
than/IN
those/DT
with/IN
the/DT
CC/NN
genotype/NN
(/(
p/NN
=/JJ
0.032/CD
)/)
./.
====================
The/DT
diabetic/JJ
factors/NNS
,/,
such/JJ
as/IN
insulin/NN
and/CC
C-peptide/NN
,/,
were/VBD
also/RB
higher/JJR
in/IN
the/DT
children/NN
with/IN
the/DT
TT/NN
genotype/NN
than/IN
those/DT
with/IN
the/DT
CC/NN
genotype/NN
(/(
p/NN
=0.029/CD
vs./CC
p/NN
=/JJ
0.004/CD
,/,
respectively/RB
)/)
(/(
Table/JJ
2/CD
)/)
./.
====================
On/IN
the/DT
other/JJ
hand/NN
,/,
the/DT
alleles/NNS
of/IN
the/DT
KLF5/NN
gene/NN
showed/VBD
a/DT
divergent/JJ
trend/NN
when/WRB
compared/VBN
with/IN
the/DT
genotype/NN
./.
====================
For/IN
example/NN
,/,
the/DT
children/NN
with/IN
the/DT
T/NN
allele/NN
had/VBD
significantly/RB
lower/JJR
TC/NN
and/CC
LDL-C/NN
than/IN
those/DT
with/IN
the/DT
C/NN
allele/NN
,/,
regardless/RB
of/IN
BMR/NN
(/(
Table/JJ
3/CD
)/)
./.
====================
Risk/NN
factors/NNS
related/JJ
to/TO
BMR/NN
====================
The/DT
parametric/JJ
Pearson/NNP
correlation/NN
analysis/NN
of/IN
the/DT
data/NNS
revealed/VBD
that/IN
BMR/NN
was/VBD
significantly/RB
positively/RB
correlated/VBN
with/IN
height/RB
(/(
r/NN
=/JJ
0.888/CD
,/,
p/NN
</JJR
0.001/CD
)/)
,/,
weight/RB
(/(
r/NN
=/JJ
0.873/CD
,/,
p/NN
</JJR
0.001/CD
)/)
,/,
BMI/NNP
(/(
r/NN
=/JJ
0.669/CD
,/,
p/NN
</JJR
0.001/CD
)/)
,/,
fat/JJ
mass/RB
(/(
r/NN
=/JJ
0.596/CD
,/,
p/NN
</JJR
0.001/CD
)/)
,/,
muscle/RB
(/(
r/NN
=/JJ
1.000/CD
,/,
p/NN
</JJR
0.001/CD
)/)
,/,
insulin/RB
(/(
r/NN
=/JJ
0.377/CD
,/,
p/NN
=/JJ
0.002/CD
)/)
,/,
and/CC
C-peptide/JJ
(/(
r/NN
=/JJ
0.618/CD
,/,
p/NN
</JJR
0.001/CD
)/)
(/(
data/NNS
not/RB
shown/VBN
)/)
./.
====================
Because/IN
the/DT
value/NN
of/IN
BMR/NN
and/CC
RMR/NN
was/VBD
similar/JJ
to/TO
each/DT
other/JJ
,/,
we/PRP
analyzed/VBD
the/DT
regression/NN
equation/NN
of/IN
BMR/NN
with/IN
the/DT
contributors/NNS
./.
====================
Linear/JJ
regression/NN
analysis/NN
was/VBD
performed/VBN
to/TO
estimate/VB
the/DT
relative/JJ
contributions/NNS
of/IN
BMI/NN
,/,
muscle/NN
,/,
fat/NN
mass/NN
,/,
insulin/NN
,/,
and/CC
cholesterol/NN
to/TO
the/DT
inter-individual/JJ
variations/NNS
of/IN
BMR/NN
./.
====================
In/IN
the/DT
linear/JJ
regression/NN
analysis/NN
,/,
BMI/NN
and/CC
muscle/NN
mass/NN
were/VBD
correlated/VBN
with/IN
BMR/NN
in/IN
every/DT
genotype/NN
of/IN
KLF5/NN
,/,
whereas/IN
insulin/NN
and/CC
C-peptide/NN
were/VBD
not/RB
associated/VBN
with/IN
BMR/NN
in/IN
children/NN
with/IN
the/DT
CT/NN
and/CC
TT/NN
compared/VBN
to/TO
CC/NN
genotype/NN
./.
====================
It/PRP
was/VBD
interesting/JJ
that/IN
TC/NN
was/VBD
negatively/RB
correlated/VBD
with/IN
BMR/NN
in/IN
only/RB
the/DT
TT/NN
genotype/NN
in/IN
contrast/NN
to/TO
the/DT
CC/NN
or/CC
CT/NN
genotype/NN
./.
====================
(/(
Figs/NNS
./.
====================
1/CD
and/CC
2/CD
)/)
./.
====================
Multiple/JJ
linear/JJ
regression/NN
analysis/NN
was/VBD
performed/VBN
to/TO
estimate/VB
the/DT
relative/JJ
contribution/NN
of/IN
age/NN
,/,
muscle/NN
,/,
RI/NN
,/,
tricep/NN
,/,
glucose/NN
,/,
and/CC
insulin/NN
to/TO
BMR/NN
in/IN
children/NN
./.
====================
We/PRP
identified/VBD
that/WDT
age/NN
,/,
muscle/NN
,/,
RI/NN
,/,
tricep/NN
,/,
WHR/NN
,/,
and/CC
fat/NN
mass/NN
could/MD
explain/VB
100/CD
%/NN
of/IN
BMR/NN
(/(
adjusted/VBN
r2/NN
=/JJ
1.000/CD
,/,
p/NN
</JJR
0.001/CD
)/)
in/IN
children/NN
(/(
Table/JJ
4/CD
)/)
./.
====================
In/IN
the/DT
high-BMR/JJ
group/NN
,/,
we/PRP
observed/VBD
that/IN
higher/JJR
muscle/NN
,/,
fat/JJ
mass/NN
,/,
and/CC
C-peptide/NN
affected/VBN
the/DT
increase/NN
of/IN
BMR/NN
in/IN
children/NN
with/IN
TT/NN
genotype/NN
(/(
p/NN
</JJR
0.001/CD
,/,
p/NN
</JJR
0.001/CD
,/,
and/CC
p/NN
=/JJ
0.018/CD
,/,
respectively/RB
)/)
,/,
while/IN
RI/NN
could/MD
explain/VB
the/DT
usual/JJ
decrease/NN
in/IN
BMR/NN
(/(
adjusted/VBN
r2/NN
=/JJ
1.000/CD
,/,
p/NN
</JJR
0.001/CD
)/)
./.
====================
Our/PRP$
prediction/NN
equation/JJ
of/IN
BMR/NN
including/VBG
age/NN
,/,
muscle/NN
,/,
RI/NN
,/,
tricep/RB
,/,
WHR/NN
,/,
and/CC
fat/JJ
mass/NN
specific/JJ
for/IN
children/NN
from/IN
10/CD
to/TO
13/CD
years/NNS
old/JJ
is/VBZ
as/IN
follows/VBZ
:/:
BMR/NN
=/JJ
369.634+/JJ
(/(
1.038/CD
×/NNP
age/NN
)/)
+/CC
(/(
22.452/CD
×/NNP
muscle/NN
)/)
-/:
(/(
0.087/CD
×/NNP
RI/NN
)/)
+/CC
(/(
0.090/CD
×/NNP
tricep/JJ
)/)
+/CC
(/(
11.147/CD
×/NNP
WHR/NN
)/)
+/CC
(/(
0.532/CD
×/NNP
fat/JJ
mass/NN
)/)
./.
====================
This/DT
study/NN
was/VBD
the/DT
first/JJ
report/NN
of/IN
a/DT
KLF5/NN
SNP/NN
(/(
rs3782933/NN
)/)
involved/VBN
in/IN
the/DT
susceptibility/NN
to/TO
BMR/NN
in/IN
Korean/JJ
elementary/JJ
school/NN
children/NN
./.
====================
Children/NN
with/IN
the/DT
TT/NN
genotype/NN
had/VBD
significantly/RB
higher/JJR
BMR/NN
,/,
muscle/NN
,/,
HLD-C/NN
,/,
insulin/NN
,/,
and/CC
C-peptide/NN
and/CC
lower/JJR
LDL-C/NN
than/IN
those/DT
with/IN
the/DT
wild-type/JJ
CC/NN
./.
====================
However/RB
,/,
we/PRP
found/VBD
that/IN
BMI/NN
,/,
muscle/NN
,/,
and/CC
fat/NN
mass/NN
could/MD
explain/VB
the/DT
usual/JJ
increase/VBP
in/IN
BMR/NN
in/IN
every/RB
genotype/NN
in/IN
KLF5/NN
,/,
whereas/IN
insulin/NN
and/CC
C-peptide/NN
were/VBD
not/RB
associated/VBN
with/IN
the/DT
increase/NN
of/IN
BMR/NN
,/,
except/IN
wild-type/JJ
,/,
in/IN
the/DT
linear/JJ
regression/NN
analysis/NN
./.
====================
Using/VBG
multiple/JJ
linear/JJ
regression/NN
analysis/NN
,/,
we/PRP
estimated/VBD
the/DT
predicting/VBG
equation/NN
of/IN
BMR/NN
in/IN
children/NN
./.
====================
In/IN
the/DT
high-BMR/JJ
group/NN
,/,
TT/NN
genotype/NN
increased/VBD
BMR/NN
according/VBG
to/TO
muscle/NN
,/,
fat/NN
mass/NN
,/,
and/CC
C-peptide/NN
,/,
and/CC
there/EX
was/VBD
an/DT
inverse/JJ
correlation/NN
between/IN
BMR/NN
and/CC
RI/NN
(/(
adjust/RB
r2/NN
=/JJ
1.000/CD
,/,
p/NN
</JJR
0.001/CD
)/)
./.
====================
Our/PRP$
results/NNS
suggested/VBD
an/DT
association/NN
between/IN
the/DT
TT/NN
mutant/JJ
homozygotes/NNS
of/IN
KLF5/NN
rs3782933/NN
and/CC
BMR/NN
in/IN
Korean/JJ
children/NN
./.
====================
BMR/NN
is/VBZ
affected/VBN
by/IN
many/JJ
factors/NNS
,/,
such/JJ
as/IN
age/NN
,/,
gender/NN
,/,
body/NN
composition/NN
,/,
and/CC
genetic/JJ
variation/NN
./.
====================
BMR/NN
measurement/NN
in/IN
humans/NNS
was/VBD
primarily/RB
used/VBN
for/IN
the/DT
diagnosis/NN
of/IN
hypo-/JJ
and/CC
hyperthyroidism/NN
./.
====================
Recently/RB
,/,
BMR/NN
was/VBD
used/VBN
to/TO
estimate/VB
human/JJ
energy/NN
and/CC
food/NN
requirements/NNS
as/IN
well/RB
as/IN
the/DT
diagnosis/NN
of/IN
thyroid/NN
disease/NN
,/,
diabetes/VBZ
,/,
and/CC
leukemia/NN
[/(
21/CD
]/)
./.
====================
Up/IN
to/TO
the/DT
present/JJ
,/,
alleles/NNS
of/IN
specific/JJ
genes/NNS
,/,
such/JJ
as/IN
UCP1/NN
,/,
LPL/NN
,/,
and/CC
beta3-AR/JJ
,/,
were/VBD
considered/VBN
to/TO
play/VB
a/DT
major/JJ
role/NN
in/IN
the/DT
development/NN
of/IN
metabolic/JJ
complications/NNS
in/IN
the/DT
obese/JJ
population/NN
[/(
22/CD
]/)
./.
====================
Moreover/RB
,/,
some/DT
reports/NNS
suggested/VBD
that/IN
the/DT
variation/NN
in/IN
the/DT
beta3-adrenergic/JJ
receptor/NN
gene/NN
influences/VBZ
BMR/NN
in/IN
obese/DT
subjects/NNS
and/CC
that/IN
the/DT
synergistic/JJ
effect/NN
of/IN
polymorphisms/NNS
in/IN
UCP1/NN
and/CC
beta3-adrenergic/JJ
receptor/NN
genes/NNS
leads/VBZ
to/TO
a/DT
lower/JJR
BMR/NN
[/(
15/CD
,/,
23/CD
]/)
./.
====================
Recently/RB
,/,
Suchanek/NN
et/FW
al/JJ
./.
====================
[/(
24/CD
]/)
investigated/VBD
the/DT
association/NN
between/IN
an/DT
alpha2/NN
Heremans-Schmid/NN
glycoprotein/NN
(/(
AHSG/NN
)/)
gene/NN
polymorphism/NN
and/CC
obesity/NN
./.
====================
There/EX
was/VBD
a/DT
significant/JJ
correlation/NN
between/IN
homozygotes/NNS
of/IN
AHSG/NN
and/CC
increased/VBD
BMR/NN
[/(
24/CD
]/)
./.
====================
However/RB
,/,
the/DT
association/NN
of/IN
the/DT
variation/NN
in/IN
KLF5/NN
and/CC
BMR/NN
has/VBZ
not/RB
been/VBN
confirmed/VBN
yet/RB
in/IN
Korean/JJ
children/NN
./.
====================
Although/IN
we/PRP
identified/VBD
the/DT
novel/JJ
genetic/JJ
variation/NN
in/IN
a/DT
noncoding/JJ
region/NN
of/IN
KLF5/NN
,/,
this/DT
SNP/NN
might/MD
affect/VB
complex/NN
diseases/NNS
,/,
such/JJ
as/IN
obesity/NN
and/CC
diabetes/VBZ
./.
====================
Many/JJ
disease-associated/JJ
mutations/NNS
are/VBP
predicted/VBN
to/TO
be/VB
SNPs/NNS
./.
====================
Some/DT
of/IN
the/DT
SNPs/NNS
associated/VBN
with/IN
complex/NN
diseases/NNS
might/MD
be/VB
located/JJ
in/IN
the/DT
coding/VBG
and/or/CC
noncoding/JJ
region/NN
and/CC
lead/VBP
to/TO
alterations/NNS
in/IN
the/DT
function/NN
of/IN
the/DT
protein/NN
[/(
25/CD
]/)
./.
====================
Recently/RB
,/,
Oishi/NNP
et/FW
al/JJ
./.
====================
[/(
1/CD
]/)
showed/VBD
that/IN
a/DT
novel/JJ
signaling/NN
and/CC
transcriptional/JJ
network/NN
involving/VBG
MEF2A/NN
and/CC
KLF5/NN
-1,282/CD
bp/NN
plays/VBZ
a/DT
crucial/JJ
role/NN
in/IN
the/DT
pathogenesis/NN
of/IN
hypertension/NN
and/CC
that/IN
the/DT
KLF5/NN
promoter/NN
allele/NN
(/(
-1282A/CD
)/)
is/VBZ
associated/VBN
with/IN
a/DT
higher/JJR
prevalence/NN
of/IN
hypertension/NN
[/(
1/CD
]/)
./.
====================
KLF5/NN
has/VBZ
also/RB
been/VBN
involved/VBN
in/IN
vascular/JJ
smooth/JJ
muscle/NN
cell/NN
differentiation/NN
,/,
growth/NN
,/,
and/CC
gene/NN
expression/NN
[/(
3/CD
]/)
./.
====================
In/IN
this/DT
population/NN
,/,
we/PRP
divided/VBD
them/PRP
into/IN
two/CD
groups/NNS
by/IN
BMI/NN
:/:
normal/JJ
weight/NN
and/CC
overweight/JJ
./.
====================
Children/NN
who/WP
are/VBP
overweight/VBN
have/VBP
the/DT
potential/JJ
to/TO
be/VB
obese/DT
adults/NNS
when/WRB
they/PRP
grow/VBP
up/IN
./.
====================
We/PRP
could/MD
infer/VB
from/IN
the/DT
relationship/NN
between/IN
the/DT
KLF5/NN
polymorphism/NN
and/CC
BMR/NN
that/DT
the/DT
variation/NN
of/IN
KLF/NN
is/VBZ
associated/VBN
with/IN
obesity/NN
./.
====================
Several/JJ
studies/NNS
of/IN
diverse/JJ
ethnic/JJ
groups/NNS
,/,
including/VBG
Pima/NN
Indians/NNS
,/,
Caucasians/NNS
,/,
and/CC
Japanese/JJ
,/,
have/VBP
demonstrated/VBN
that/IN
obese/DT
individuals/NNS
with/IN
type/NN
2/CD
diabetes/NNS
have/VBP
a/DT
higher/JJR
BMR/NN
compared/VBN
to/TO
the/DT
obese/JJ
non-diabetic/JJ
populations/NNS
[/(
26/CD
]/)
./.
====================
In/IN
our/PRP$
result/NN
,/,
58/CD
%/NN
of/IN
children/NN
in/IN
the/DT
high-BMR/JJ
group/NN
were/VBD
overweight/VBN
,/,
and/CC
the/DT
children/NN
with/IN
the/DT
TT/NN
mutant/JJ
homozygote/NN
of/IN
KLF5/NN
came/VBD
under/IN
the/DT
high-BMR/JJ
group/NN
./.
====================
Recently/RB
,/,
the/DT
predicting/VBG
equations/NNS
for/IN
BMR/NN
have/VBP
been/VBN
verified/VBN
in/IN
many/JJ
populations/NNS
[/(
12/CD
,/,
27-29/CD
]/)
./.
====================
To/TO
cross-validate/VB
three/CD
predicting/VBG
equations/NNS
for/IN
BMR/NN
established/VBN
by/IN
the/DT
Schofield/JJ
database/NN
,/,
Henry/RB
,/,
and/CC
Cole/NN
,/,
Ramirez-Zea/NN
M/NN
used/VBN
mean/JJ
values/NNS
for/IN
age/NN
,/,
weight/NN
,/,
height/RB
,/,
and/CC
BMR/NN
./.
====================
These/DT
findings/NNS
suggested/VBD
that/IN
the/DT
equation/NN
seemed/VBN
to/TO
be/VB
appropriate/JJ
to/TO
estimate/VB
BMR/NN
in/IN
men/NNS
only/RB
,/,
not/RB
women/NNS
[/(
28/CD
]/)
./.
====================
Another/DT
study/NN
indicated/VBD
that/IN
a/DT
new/JJ
equation/NN
may/MD
be/VB
more/RBR
appropriate/JJ
for/IN
calculating/JJ
BMR/NN
using/VBG
age/NN
,/,
height/RB
,/,
weight/NN
,/,
and/CC
fat/NN
in/IN
obese/DT
children/NN
[/(
27/CD
]/)
./.
====================
In/IN
our/PRP$
equation/NN
,/,
we/PRP
determined/VBD
a/DT
BMR/NN
equation/NN
for/IN
children/NN
between/IN
the/DT
ages/NNS
of/IN
10/CD
and/CC
13/CD
years/NNS
old/JJ
based/VBN
on/IN
age/NN
,/,
muscle/NN
,/,
RI/NN
,/,
tricep/NN
,/,
WHR/NN
,/,
and/CC
fat/NN
mass/NN
./.
====================
Our/PRP$
predicting/VBG
equation/NN
in/IN
children/NN
was/VBD
similar/JJ
to/TO
the/DT
previous/JJ
studies/NNS
./.
====================
In/IN
the/DT
normal-weight/JJ
group/NN
,/,
we/PRP
observed/VBD
that/IN
the/DT
variables/NNS
of/IN
age/NN
,/,
weight/NN
,/,
muscle/NN
,/,
RI/NN
,/,
glucose/NN
,/,
and/CC
insulin/NN
were/VBD
significant/JJ
predictors/NNS
of/IN
BMR/NN
,/,
which/WDT
accounted/VBD
for/IN
100/CD
%/NN
of/IN
the/DT
variation/NN
in/IN
BMR/NN
./.
====================
However/RB
,/,
the/DT
final/JJ
model/NN
of/IN
our/PRP$
equation/NN
for/IN
BMR/NN
in/IN
the/DT
overweight/JJ
group/NN
included/VBD
both/CC
weight/NN
and/CC
muscle/NN
(/(
data/NNS
not/RB
shown/VBN
)/)
./.
====================
On/IN
the/DT
other/JJ
hand/NN
,/,
we/PRP
divided/VBD
them/PRP
into/IN
2/CD
groups/NNS
:/:
low-/JJ
and/CC
high-BMR/JJ
group/NN
./.
====================
In/IN
the/DT
high-BMR/JJ
group/NN
,/,
we/PRP
established/VBD
the/DT
predictive/JJ
equation/NN
using/VBG
muscle/NN
,/,
fat/NN
mass/NN
,/,
RI/NN
,/,
and/CC
C-peptide/NN
./.
====================
We/PRP
observed/VBD
an/DT
inverse/JJ
correlation/NN
between/IN
BMR/NN
and/CC
RI/NN
in/IN
the/DT
high-BMR/JJ
group/NN
,/,
and/CC
the/DT
children/NN
with/IN
the/DT
TT/NN
genotype/NN
belonged/VBD
to/TO
the/DT
high-BMR/JJ
group/NN
./.
====================
These/DT
results/NNS
indicated/VBD
that/IN
the/DT
children/NN
with/IN
the/DT
TT/NN
genotype/NN
have/VBP
a/DT
higher/JJR
BMR/NN
compared/VBN
with/IN
the/DT
children/NN
with/IN
the/DT
CC/NN
genotype/NN
./.
====================
Although/IN
the/DT
mean/JJ
insulin/NN
value/NN
was/VBD
higher/JJR
in/IN
the/DT
children/NN
with/IN
the/DT
TT/NN
genotype/NN
than/IN
those/DT
with/IN
the/DT
CC/NN
genotype/NN
,/,
there/EX
was/VBD
no/DT
significant/JJ
association/NN
between/IN
HOMA-IR/NN
and/CC
TT/NN
genotype/NN
in/IN
our/PRP$
subjects/NNS
./.
====================
We/PRP
postulated/VBD
that/IN
the/DT
relation/NN
of/IN
insulin/NN
and/CC
HOMA-IR/NN
may/MD
contribute/VB
to/TO
insulin/NN
resistance/NN
(/(
IR/NN
)/)
in/IN
our/PRP$
children/NN
./.
====================
IR/NN
was/VBD
calculated/VBN
according/VBG
to/TO
HOMA/NN
using/VBG
fasting/JJ
insulin/NN
and/CC
glucose/NN
concentrations/NNS
[/(
30/CD
]/)
./.
====================
Children/NN
who/WP
were/VBD
overweight/VBN
have/VBP
a/DT
higher/JJR
morbidity/NN
rate/NN
of/IN
obesity/NN
than/IN
children/NN
with/IN
normal/JJ
weight/NN
./.
====================
Obese/DT
adults/NNS
have/VBP
more/RBR
IR/NN
than/IN
normal/JJ
,/,
which/WDT
may/MD
predispose/VB
them/PRP
to/TO
diabetes/NNS
[/(
30/CD
]/)
./.
====================
Obesity-induced/JJ
IR/NN
is/VBZ
the/DT
major/JJ
contributor/NN
of/IN
metabolic/JJ
syndrome/NN
,/,
and/CC
both/CC
obesity/NN
and/CC
IR/NN
are/VBP
components/NNS
of/IN
metabolic/JJ
syndrome/NN
[/(
31/CD
,/,
32/CD
]/)
./.
====================
However/RB
,/,
we/PRP
could/MD
not/RB
observe/VB
IR/NN
./.
====================
Also/RB
,/,
the/DT
insulin/NN
value/NN
and/CC
HOMA-IR/NN
were/VBD
not/RB
involved/VBN
in/IN
the/DT
equation/NN
of/IN
the/DT
overweight/JJ
group/NN
./.
====================
In/IN
the/DT
high-BMR/JJ
group/NN
only/RB
,/,
we/PRP
observed/VBD
that/IN
the/DT
higher/JJR
C-peptide/NN
affected/VBN
the/DT
increase/NN
of/IN
BMR/NN
in/IN
children/NN
with/IN
the/DT
TT/NN
genotype/NN
./.
====================
Therefore/RB
,/,
obese/DT
children/NN
with/IN
the/DT
TT/NN
genotype/NN
may/MD
have/VB
no/DT
potential/JJ
for/IN
becoming/VBG
obese/DT
adults/NNS
with/IN
metabolic/JJ
syndrome/NN
./.
====================
There/EX
are/VBP
several/JJ
limitations/NNS
in/IN
this/DT
study/NN
./.
====================
First/RB
of/IN
all/DT
,/,
a/DT
sample/JJ
size/NN
of/IN
this/DT
study/NN
was/VBD
too/RB
small/JJ
,/,
because/IN
1/CD
)/)
it/PRP
was/VBD
necessary/JJ
to/TO
use/VB
a/DT
direct/JJ
calorimeter/NN
for/IN
measuring/VBG
RMR/NN
,/,
but/CC
the/DT
device/JJ
and/CC
its/PRP$
expendables/NNS
,/,
such/JJ
as/IN
mouthpieces/NNS
,/,
were/VBD
too/RB
expensive/JJ
and/CC
not/RB
cost-effective/JJ
for/IN
our/PRP$
study/NN
./.
====================
If/IN
the/DT
children/NN
were/VBD
unable/JJ
to/TO
reach/VB
steady-state/JJ
oxygen/NN
consumption/NN
in/IN
the/DT
allotted/JJ
time/NN
of/IN
approximately/RB
10/CD
min/NN
,/,
the/DT
children/NN
repeated/VBN
numerous/JJ
times/NNS
after/IN
resting/VBG
,/,
and/CC
it/PRP
was/VBD
not/RB
easy/RB
for/IN
younger/RBR
participants/NNS
./.
====================
2/CD
)/)
Parent/JJ
's/POS
signed/JJ
permission/NN
for/IN
these/DT
children/NN
was/VBD
mandatory/JJ
at/IN
the/DT
first/JJ
visit/NN
,/,
but/CC
several/JJ
parents/NNS
and/CC
children/NN
rejected/VBD
informed/VBN
consent/NN
./.
====================
3/CD
)/)
It/PRP
was/VBD
not/RB
sufficient/JJ
to/TO
obtain/VB
the/DT
blood/NN
samples/NNS
of/IN
all/DT
children/NN
for/IN
analyzing/VBG
the/DT
genetic/JJ
polymorphism/NN
of/IN
KLF5/NN
,/,
and/CC
there/EX
was/VBD
a/DT
genotyping/JJ
error/NN
sometimes/RB
./.
====================
Second/RB
,/,
we/PRP
could/MD
not/RB
find/VB
out/IN
the/DT
citations/NNS
to/TO
explain/VB
the/DT
association/NN
between/IN
the/DT
KLF5/NN
polymorphism/NN
and/CC
BMR/NN
./.
====================
There/EX
is/VBZ
abundant/JJ
satisfactory/JJ
research/NN
showing/VBG
the/DT
predictive/JJ
equation/NN
for/IN
BMR/NN
in/IN
several/JJ
populations/NNS
./.
====================
Although/IN
we/PRP
discovered/VBD
the/DT
studies/NNS
to/TO
suggest/VB
the/DT
genes/NNS
involved/VBN
in/IN
the/DT
regulation/NN
of/IN
energy/NN
expenditure/NN
metabolism/NN
,/,
including/VBG
UCP1/NN
,/,
there/EX
was/VBD
not/RB
enough/IN
research/NN
to/TO
demonstrate/VB
the/DT
association/NN
of/IN
KLF5/NN
and/CC
BMR/NN
in/IN
this/DT
study/NN
./.
====================
In/IN
this/DT
study/NN
,/,
we/PRP
found/VBD
that/IN
the/DT
TT/NN
homozygote/NN
of/IN
KLF5/NN
plays/VBZ
a/DT
crucial/JJ
role/NN
for/IN
increasing/VBG
BMR/NN
and/CC
fat/NN
mass/NN
in/IN
Korean/JJ
children/NN
./.
====================
We/PRP
could/MD
make/VB
better/RBR
use/NN
of/IN
the/DT
novel/JJ
variations/NNS
within/IN
KLF5/NN
in/IN
a/DT
future/JJ
clinical/JJ
intervention/NN
study/NN
of/IN
obesity/NN
./.
====================
Correlation/NN
of/IN
basal/JJ
metabolic/JJ
rate/NN
(/(
BMR/NN
)/)
and/CC
clinical/JJ
variables/NNS
according/VBG
to/TO
genotype/NN
distribution/NN
of/IN
rs3782933/NN
./.
====================
Resting/VBG
metabolic/JJ
rate/NN
(/(
RMR/NN
)/)
and/CC
VO2/NN
were/VBD
positively/RB
correlated/VBD
with/IN
BMR/NN
in/IN
only/RB
the/DT
CC/NN
genotype/NN
in/IN
contrast/NN
to/TO
the/DT
CT/NN
or/CC
TT/NN
genotypes/NNS
(/(
A/DT
and/CC
B/NN
)/)
;/:
meanwhile/IN
,/,
body/NN
mass/NN
index/NN
(/(
BMI/NN
)/)
and/CC
muscle/NN
were/VBD
related/JJ
with/IN
BMR/NN
in/IN
CC/NN
,/,
CT/NN
,/,
and/CC
TT/NN
genotypes/NNS
(/(
C/NN
and/CC
D/NN
)/)
./.
====================
Correlation/NN
of/IN
basal/JJ
metabolic/JJ
rate/NN
(/(
BMR/NN
)/)
and/CC
clinical/JJ
variables/NNS
according/VBG
to/TO
genotype/NN
distribution/NN
of/IN
rs3782933/NN
./.
====================
Insulin/RB
and/CC
C-peptide/NN
were/VBD
correlated/VBN
with/IN
BMR/NN
in/IN
only/RB
the/DT
CC/NN
genotype/NN
in/IN
contrast/NN
to/TO
the/DT
CT/NN
or/CC
TT/NN
genotype/NN
(/(
A/DT
and/CC
B/NN
)/)
;/:
meanwhile/IN
,/,
cholesterol/NN
was/VBD
not/RB
associated/VBN
with/IN
BMR/NN
regardless/RB
of/IN
genotypes/NNS
(/(
C/NN
)/)
./.
====================
Genotype/NN
and/CC
allele/NN
distribution/NN
of/IN
KLF5/NN
rs3782933/NN
SNP/NN
in/IN
children/NN
(/(
n/NN
=/JJ
62/CD
)/)
====================
Anthropometric/JJ
and/CC
clinical/JJ
characteristics/NNS
of/IN
elementary/JJ
school/NN
children/NN
according/VBG
to/TO
allele/NN
and/CC
genotype/NN
of/IN
rs3782933/NN
====================
Anthropometric/JJ
and/CC
clinical/JJ
characteristics/NNS
of/IN
elementary/JJ
school/NN
children/NN
according/VBG
to/TO
allele/NN
and/CC
genotype/NN
of/IN
rs3782933/NN
====================
Stepwise/JJ
multiple/JJ
regression/NN
models/NNS
for/IN
predicting/VBG
BMR/NN
in/IN
children/NN
====================
